---
$id: https://graph.org.ai/products/commodity/51334411
$type: Product
source: UNSPSC
code: "51334411"
title: "Nonaperone"
class: "51334400"
classTitle: "Antipsychotics, synthesized"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nonaperone

**UNSPSC Code**: 51334411
**Class**: [Antipsychotics, synthesized](Antipsychotics, synthesized.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anxiolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JLD8OG7GK0. European Medicines Agency schedules Nonaperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09349MIG. Nonaperone generally arises in the molecular formula C18H24FNO. The term NONAPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21.) NONAPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nonaperone under HS 29339990 and SITC 51577. As of Q4 2014, NONAPERONE remains the US FDA Preferred Term for this commodity. Nonaperone bears US NLM identifiers UMLS ID C2983883 and NCI Concept Code C90790. SMILES: FC1CCC(C(=O)CCCN2CC3CCC(CC3)C2)CC1.

